STTK Stock Analysis: Buy, Sell, or Hold?
STTK - Shattuck Labs, Inc. Common Stock
$5.41
0.17 (3.24%)
▲
5d:
+16.85%
30d:
-11.17%
90d:
-11.6%
BUY
HIGH Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When STTK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: STTK shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: STTK shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: STTK is currently trading at $5.41, which is considered fair relative to its 30-day fair value range of $4.48 to $5.97.
Technical Outlook: Technically, STTK is in a downtrend. The price is approaching resistance at $5.24. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.2% recently.
Market Sentiment: STTK has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $14.83 (+183.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, STTK is in a downtrend. The price is approaching resistance at $5.24. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.2% recently.
Market Sentiment: STTK has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $14.83 (+183.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$4.48 -
$5.97
Company Quality Score
55/100
(HOLD)
Options IV Signal
61th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
87.5%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Options fairly priced (IV 61th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.2%)
- BULLISH: Trading 183.1% below Wall St target ($14.83)
Trading Range Analysis
30-Day Trading Range
$4.48 -
$5.97
Current vs Trading Range
FAIR
Expected Move (7 Days)
±$1.63
(30.2%)
Support & Resistance Levels
Support Level
$3.33
Resistance Level
$5.24
Current Trend
Downtrend
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-10.16
Wall Street Target
$14.83
(+183.1%)
Revenue Growth (YoY)
-66.6%
Share & Embed Analysis
Last updated: June 23, 2026 12:58 PM ET
Data refreshes hourly during market hours. Next update: 1:58 PM
Data refreshes hourly during market hours. Next update: 1:58 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is STTK showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 65 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 58 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 60 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 61 BUY |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$51 | 69 BUY |
